INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
KR

Kelly Jason R

Director, See remarksCIK 0001845677

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 1
Max Insider Score50
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
55.7K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Ginkgo Bioworks Holdings, Inc.Director, See remarks · Oct 21, 2026
19
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M
—
25.8K sh
Oct 16, 2026
Oct 21, 2026
traded Oct 16, 2026
+5d
SEC FORM 4

Evidence

50
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$463K
45.7K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

15
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
55.7K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence

19
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
25.8K sh
Oct 16, 2026Oct 21, 2026
traded Oct 16, 2026
+5dSEC FORM 4

Evidence